newsfilter
← Latest News
GlobeNewswire·

Marker Therapeutics Appoints Monic Stuart, M.D., as Chief Medical Officer

HOUSTON, May 08, 2023 (GLOBE NEWSWIRE) -- Marker Therapeutics, Inc. (NASDAQ:MRKR), a clinical-stage immuno-oncology company focusing on developing next-generation T cell-based immunotherapies for the treatment of